3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
3
Neoplasms
3
Marijuana Abuse
3
Recurrence
1
Parasomnias
1
Pancreatic Neoplasms
1
Nausea
1
Glioblastoma
1
Chronic Pain
1
Cachexia
1
Brain Neoplasms
1
Anxiety Disorders
1
Anorexia
1
Advanced Malignant Solid Tumor
1
Interventions
siltuximab
1
nabiximols
1
erenumab
1
Sufentanil
1
Standard of Care
1
Saline Solution
1
Pain Management
1
Medical Marijuana
1
Donepezil
1
Botulinum Toxins, Type A
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Chronic Pain
×
nabiximols
×
Clear all
NCT03522467
2019-09-25
COPE
Aurora Cannabis Inc
Phase 2
Unknown
40 enrolled